These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35743361)

  • 1. Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy.
    Musiała A; Donizy P; Augustyniak-Bartosik H; Jakuszko K; Banasik M; Kościelska-Kasprzak K; Krajewska M; Kamińska D
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.
    Wada T; Nangaku M
    Clin Kidney J; 2015 Dec; 8(6):708-15. PubMed ID: 26613029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
    Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
    Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.
    Winnicki W; Sunder-Plassmann G; Sengölge G; Handisurya A; Herkner H; Kornauth C; Bielesz B; Wagner L; Kikić Ž; Pajenda S; Reiter T; Schairer B; Schmidt A
    Sci Rep; 2019 Sep; 9(1):13783. PubMed ID: 31551522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates.
    Königshausen E; Sellin L
    Biomed Res Int; 2016; 2016():3765608. PubMed ID: 27200372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.
    Harita Y; Ishizuka K; Tanego A; Sugawara N; Chikamoto H; Akioka Y; Tsurumi H; Miura K; Gotoh Y; Tsujita M; Yamamoto T; Horike K; Takeda A; Oka A; Igarashi T; Hattori M
    Pediatr Nephrol; 2014 Sep; 29(9):1553-60. PubMed ID: 24705794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
    Rashmi P; Sigdel TK; Rychkov D; Damm I; Da Silva AA; Vincenti F; Lourenco AL; Craik CS; Reiser J; Sarwal MM
    Ann Transl Med; 2023 Jun; 11(9):315. PubMed ID: 37404982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin.
    Hladunewich MA; Cattran D; Sethi SM; Hayek SS; Li J; Wei C; Mullin SI; Reich HN; Reiser J; Fervenza FC
    Kidney Int Rep; 2022 Jan; 7(1):68-77. PubMed ID: 35005315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability factors in focal and segmental glomerulosclerosis.
    Reiser J; Nast CC; Alachkar N
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J; Li YW; He Q
    Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
    Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
    Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation.
    Harel E; Shoji J; Abraham V; Miller L; Laszik Z; Thurison T; King A; Olshen A; Leung J; Szabo G; Hann B; Høyer-Hansen G; Craik CS; Vincenti F
    Clin Transplant; 2019 Mar; 33(3):e13487. PubMed ID: 30689221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unwinding focal segmental glomerulosclerosis.
    Peev V; Hahm E; Reiser J
    F1000Res; 2017; 6():466. PubMed ID: 28491286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
    Wei C; El Hindi S; Li J; Fornoni A; Goes N; Sageshima J; Maiguel D; Karumanchi SA; Yap HK; Saleem M; Zhang Q; Nikolic B; Chaudhuri A; Daftarian P; Salido E; Torres A; Salifu M; Sarwal MM; Schaefer F; Morath C; Schwenger V; Zeier M; Gupta V; Roth D; Rastaldi MP; Burke G; Ruiz P; Reiser J
    Nat Med; 2011 Jul; 17(8):952-60. PubMed ID: 21804539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.
    Trimarchi H
    World J Nephrol; 2013 Nov; 2(4):103-10. PubMed ID: 24255893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
    Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
    BMC Med; 2014 May; 12():81. PubMed ID: 24884842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb.
    Schenk H; Müller-Deile J; Schmitt R; Bräsen JH; Haller H; Schiffer M
    J Clin Apher; 2017 Dec; 32(6):444-452. PubMed ID: 28370393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.
    Kronbichler A; Saleem MA; Meijers B; Shin JI
    J Immunol Res; 2016; 2016():2068691. PubMed ID: 27504461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.